Urocortin expression in human pituitary gland and pituitary adenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3842-3850

  Iino, Kazumi ^a,c   Sasano, Hironobu ^a   Oki, Yutaka ^c   Andoh, Noriaki ^a   Shin, Ryong Woon ^a   Kitamoto, Tetsuyuki ^a   Totsune, Kazuhito ^a   Takahashi, Kazuhiro ^a   Suzuki, Hiroyoshi ^b   Nagura, Hiroshi ^a   Yoshimi, Teruya ^c  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE; UROCORTIN;

AMINO ACID SEQUENCE; ARTICLE; CHILD; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HYPOPHYSIS ADENOMA; IMAGE ANALYSIS; IMMUNOREACTIVITY; INFANT; NEWBORN; PITUITARY GLAND EXAMINATION; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; TISSUE SECTION;

MAMMALIA;

EID: 9844220858     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.11.4371     Document Type: Article

References (29)

1. Vaughan J, Donaldson C, Bittencourt J, et al. 1995 Urocortin, a mammalian neuropeptide related to fish urotensin 1 and to corticotropin-releasing factor. Nature. 378:287-292.
2. Donaldson CJ, Sutton SW, Perrin MH, et al. 1996 Cloning and characterization of human urocortin. Endocrinology. 137:2167-2170.
3. Beham DP, Khongsaly O, Ling N, De Souza EB. 1996 Urocortin interaction with corticotropin-releasing factor (CRF) binding protein (CRF-BP): a novel mechanism for elevating 'free' CRF levels in human brain. Brain Res. 725:263-267.
4. Lightman SL. 1995 From stress to cognition. Nature. 378:233-234.
5. Turnbull AV, Vale W, Rivier C. 1996 Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats. Eur J Pharmacol. 303:213-216.
6. Oki Y, Iwabuchi M, Watanabe F, et al. Distribution of urocortin immunoreactivity and mRNA in rat central nervous system. Proc of the 79th Annual Meet of The Endocrine Soc. 1997; 513.
7. Nicholson WE, Davis DR, Sherrell BJ, Orth DN. 1984 Rapid radioimmunoassay for corticotropin in unextracted human plasma. Clin Chem. 30:259-265.
8. Petraglia F, Florio P, Gallo R, et al. 1996 Human placenta and fetal membranes express human urocortin mRNA and peptide. J Clin Endocrinol Metab. 81:3807-3810.
9. Shin R-W, Iwaki T, Kitamoto T, Tateishi J. 1991 Methods in laboratory investigation. Hydrated autoclave pretreatment enhances TAU immunoreactivity in formalin-fixed normal and Alzheimer's disease brain tissues. Lab Invest. 64:693-702.
10. Sasano H, Shizawa S, Suzuki T, et al. 1995 Ad4BP in the human adrenal cortex and its disorders. J Clin Endocrinol Metab. 80:2378-2380.
11. Sasano H, Date F, Imatani A, Asaki S, Nagura H. 1993 Double immunostaining of c-erbB-2 and p53 in human stomach cancer cells. Hum Pathol. 24:584-589.
12. Montone KT, Brigati DJ. 1994 In situ molecular pathology: instrumentation, oligonucleotides, and viral nucleic acid detection. J Histothechnol. 17:195-201.
13. Sasano H, Uzuki M, Sawai T, et al. 1997 Aromatase in human bone tissue. J Bone Miner Res. 12:1416-1423.
14. Felgar RE, Montone KT, Furth EE. 1995 A rapid method for the detection of hepatitis C virus RNA by in situ hybridization. Mod Pathol. 9:696-702.
15. Horvath E, Kovacs K. 1991 The Adenohypophysis. In: Kovacs K, Asa SL, eds. Functional endocrine pathology. Boston: Blackwell; vol 1:245-267.
16. Lovenberg TW, Liaw CW, Grigoriadis DE, et al. 1995 Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor sub-type from rat brain. Proc Natl Acad Sci USA. 92:836-840.
17. Potter E, Sutton S, Donaldson C, et al. 1994 Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA. 91:8777-781.
18. Lovenberg TW, Chalmers DT, Liu C, De Souza EB. 1995 CRF2 alpha and CRF2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:4139-4142.
19. Peillon F, Le Dafniet M, Pagesy P, et al. 1991 Neuropeptides of anterior pituitary origin. Autocrine or paracrine functions? Pathol Res Pract. 187:577-580.
20. Houben H, Denef C. 1994 Bioactive peptides in anterior pituitary cells. Peptides. 15:547-582.
21. Arnaout MA, Garthwaite TL, Martinson DA, Hagen TC. 1986 Vasoactive intestinal peptide is synthesized in anterior pituitary tissue. Endocrinology. 119:2052-2057.
22. Nagy G, Mulchahey JJ, Neill JD. 1987 Autocrine control of prolactin secretion by vasoactive intestinal peptide. Endocrinology. 122:364-366.
23. Roth KA, Krause JE. 1990 Substance-P is present in a subset of thyrotrophs in the human pituitary. J Clin Endocrinol Metab. 71:1089-1095.
24. Morel G, Chayvialle JA, Kerdelhue B, Dubois PM. 1981 Ultrastructual evidence for endogenous substance-P-like immunoreactivity in the rat pituitary gland. Neuroendocrinology. 35:86-92.
25. Steel JH, Gon G, Giaid A, et al. 1992 Localization of calcitonin gene-related peptide in the rat and human pituitary gland using immunocytochemistry and in situ hybridization. Ann NY Acad of Sci. 657:135-154.
26. Mai JK, Stephens PH, Hopf A, Cuello AC. 1986 Substance P in the human brain. Neuroscience. 17:709-739.
27. Tschopp FA, Henke H, Petermann JB, et al. 1985 Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary. Proc Natl Acad Sci USA. 82:248-252.
28. Zhu X, Robertson JT, Sacks HS, Dohan FC Jr, Tseng JL, Desiderio DM. 1995 Opioid and tachykinin neuropeptides in prolactin-secreting human pituitary adenomas. Peptides. 16:1097-1107.
29. Hsu DW, Riskind PN, Hedley-Whyte ET. 1989 Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study. Am J Pathol. 135:329-338.